Does SIMVASTATIN Cause Hepatomegaly? 66 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Hepatomegaly have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.2% of all adverse event reports for SIMVASTATIN.
66
Reports of Hepatomegaly with SIMVASTATIN
0.2%
of all SIMVASTATIN reports
17
Deaths
26
Hospitalizations
How Dangerous Is Hepatomegaly From SIMVASTATIN?
Of the 66 reports, 17 (25.8%) resulted in death, 26 (39.4%) required hospitalization, and 12 (18.2%) were considered life-threatening.
Is Hepatomegaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hepatomegaly?
METHOTREXATE (276)
ADALIMUMAB (225)
RUXOLITINIB (213)
CYCLOPHOSPHAMIDE (170)
VINCRISTINE (136)
ACETAMINOPHEN (126)
RITUXIMAB (115)
DEXAMETHASONE (104)
PREDNISONE (101)
SECUKINUMAB (90)
Which SIMVASTATIN Alternatives Have Lower Hepatomegaly Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS